Le Lézard
Classified in: Health
Subjects: LAW, POL, AVO

Job Creators Network Calls for Nationwide Suspension of OSHA Mandate Following Today's Favorable Ruling


WASHINGTON, Nov. 6, 2021 /PRNewswire/ -- Today, a three judge panel at the Fifth Circuit Court of Appeals temporarily blocked OSHA's vaccine mandate saying petitioners "give cause to believe there are grave statutory and constitutional issues with the Mandate."

Alfredo Ortiz, President and CEO of Job Creators Network, released the following statement: 

"We applaud the court's swift action on issuing the stay in the 5th Circuit but it is paramount that all businesses, regardless of location, be able to breathe at least a temporary sigh of relief. For that reason, we filed with the 8th Circuit this afternoon asking to enforce the suspension of the mandate nationwide. President Biden is completely out of touch with reality and is under the misguided impression that this unconstitutional mandate will not have a detrimental impact on the small business community. We know better and we will continue to fight until it is completely eliminated."

SOURCE Job Creators Network


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: